Plain-English translation of NCT07213804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Neoplasms research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it works better than standard treatments for certain types of ovarian, fallopian tube, and peritoneal cancers. The study has three separate groups based on whether your cancer is resistant or sensitive to platinum-based chemotherapy. Researchers want to understand how well this medication works and how safe it is for you.
Current treatments for these cancers don't always work well enough, especially when cancer comes back or stops responding to chemotherapy. This trial aims to find out whether this medication offers a better option that could help people live longer and feel better.
You likely qualify if…
You likely don't qualify if…
You will receive the new medication or a standard treatment intravenously (through an IV), depending on which group you are assigned to. Some participants will receive this medication alone, while others will receive it combined with (an additional cancer drug), or you may receive standard chemotherapy instead. Your time in the study will depend on how your cancer responds and your overall health, with regular clinic visits for infusions, blood tests, and imaging scans to monitor your progress.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
United States